WASHINGTON, Feb. 14 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following recall notice:

* * *

Updated Company Announcement to August 28, 2025, Recall Announcement

Summary

Company Announcement Date: February 13, 2026

FDA Publish Date: February 13, 2026

Product Type: Dietary Supplements

Reason for Announcement: Undeclared prescription drug-Tadalafil